Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	88
Malignant neoplasm of rectum (C20)	81
Malignant neoplasm of pancreas - Malignant neoplasm of head of pancreas (C25.0)	81
Malignant neoplasm of stomach - Malignant neoplasm of cardia (C16.0)	63
Malignant neoplasm of bronchus and lung (C34.3)	50
Non-follicular lymphoma (C83.3)	39
Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0)	36
Malignant neoplasm of oesophagus - Malignant neoplasm of lower third of esophagus (C15.5)	27
Malignant neoplasm of colon - Malignant neoplasm of ascending colon (C18.2)	27
Malignant neoplasm of pancreas - Malignant neoplasm of body of pancreas (C25.1)	22

Top 10 treatments

Treatment	Number
Others therapeutic procedures to influence the immune system (8-547.0)	352
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.32)	265
Computer-assisted analysis of the images with 3D-analysis (3-990)	211
(8-831.00)	176
(9-984.7)	170
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.33)	163
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.22)	157
Computed tomography of the chest with contrast medium (3-222)	146
Computed tomography of the abdomen with contrast medium (3-225)	146
Uniform basic assessment in terminal care (1-774)	115

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0500

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
15	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
15	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
15	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Doctoral supervision
Participation in multi-centre phase III/IV studies
Lectureships / teaching posts at colleges and universities
Editors of scientific journals/textbooks
Participation in multi-centre Phase I/II studies
Project-related cooperation with colleges and universities
Student training (clinical traineeship / internship year)